On-demand webinars: The power of digital PCR in molecular testing using QIAcuity

Make every molecule count with digital PCR

Are you interested in learning about the pros and cons of digital PCR (dPCR), qPCR and NGS for molecular analysis?

Want to discover how dPCR can be used to research hematological malignancies and infectious disease?

Would you like to hear from researchers who've brought dPCR into their labs (it's easier than you think)?

If so, you won’t want to miss our on-demand dPCR webinar lineup that’ll help reinforce your knowledge and confidence in digital PCR.

Immerse yourself in a variety of dPCR applications while you learn from experienced experts how to implement this technology for molecular research. On-demand sessions include:

Oncology

Mutation analysis applications for dPCR

Learn how several teams used dPCR workflows to study gene mutations in cancer research.

Speakers:

Denise Rawcliffe, PhD, Umeå University, UMU Department of Molecular Biology, Sweden

Franziska Fahlteich University Hospital Carl Gustav Carus, Institute of Pathology, Molecular Pathology, Germany

Watch webinar

Digital PCR in oncohematology

Explore the molecular technologies currently being used in oncohematology, the advantages and disadvantages of these and how dPCR can transform testing for leukemias, lymphomas, myelomas and chronic myeloproliferative neoplasms.

Speaker:

Dr. Marzia Del Re Assistant Professor, Clinical Pharmacology and Pharmacogenetics Unit, University of Pisa, Italy

Watch webinar

Use case: How an oncohematology lab overcomes qPCR and NGS limitations using dPCR

Learn ways to overcome qPCR and NGS limitations in blood cancer sample analyses.

Speaker:

Karl Vandepoele, PhD, Molecular Biologist - Molecular Hematology, Dept. Clinical Biology, Molecular Hematology Lab, Ghent University Hospital

Watch webinar

Infectious Disease

Use case: How a public health lab uses dPCR to detect fungal DNA

Hear how one lab used dPCR to detect Aspergillus and Pneumocystis DNA.

Speaker:

Professor P. Lewis White PhD, FECMM, FRCPath Consultant Clinical Scientist and Head of the PHW Mycology Reference Laboratory, University Hospital of Wales

Watch webinar

The QIAcuity is intended for molecular biology applications. This product is not intended for the diagnosis, prevention, or treatment of a disease.

The QIAcuityDx medical device is currently under development and will be available in 20 countries in H2 2024. Product availability may vary by country specific regulatory requirements and approvals. Contact your country representative or visit www.qiagen.com for further details.